← Back to All Filings

ARTV CFO Sells $11.3K in Stock for Tax Withholding

Low SignificanceNovember 17, 2025 at 9:02:09 PM EST

Artiva Biotherapeutics, Inc.

$ARTV4CIK: 0001817241

Subscribe to track ARTV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ARTV CFO Sells $11.3K in Stock for Tax Withholding

Company: Artiva Biotherapeutics, Inc. (ARTV) Form: 4 | Filed: 2025-11-17 Significance: Low

Insider: Krishnamohan Neha Title: Chief Financial Officer | Relationship: Officer

Transaction: • Type: Tax Withholding Sale • Shares: 3,490 • Price: $3.25 • Value: $11,343 • Owned After: 99,356

Key Insight: This is a non-discretionary sale to cover tax obligations from vested stock units, not an active market sale by the insider. It holds minimal trading significance.

Market Context: The transaction represents a negligible 0.014% of the company's $80M market cap. Such sales are routine and do not typically indicate a change in insider sentiment.

Comprehensive Analysis

SEC Filing Analysis: Artiva Biotherapeutics, Inc. (ARTV)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Financial Officer executed a non-discretionary sale of shares to cover tax liabilities associated with vested restricted stock units (RSUs).
  • Market Impact: Neutral. This type of transaction is automated and does not reflect a change in insider sentiment.

Company Information

FieldValue
CompanyArtiva Biotherapeutics, Inc.
Ticker SymbolARTV
CIK0001817241
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameKrishnamohan Neha
CIK0001866171
Title/PositionChief Financial Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-15
Transaction CodeF - Payment of tax liability by withholding security
Security TypeCommon Stock
Shares Involved3,490
Price Per Share$3.25
Total Value$11,342.50
Shares Owned After99,356
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$11,342.50
% of Market Cap0.014%
Shares Transacted3,490
% of Shares OutstandingNot Available
Post-Transaction Ownership99,356 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of $11,343 is negligible compared to Artiva's $80 million market capitalization, representing only 0.014% of its total value.
  • Transaction Significance: The sale is classified as low significance. The small size relative to the company's market cap and the non-discretionary nature of the transaction (tax withholding) indicate it is a routine administrative action rather than a strategic financial decision by the insider.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction was coded 'F', indicating shares were withheld by the issuer to satisfy tax obligations on vested RSUs. This is not a discretionary open-market sale and carries no signal about the insider's outlook on the company's future performance.

Volume & Sentiment

  • Expected Volume Impact: None. This is an internal transaction and does not affect public market trading volume.
  • Sentiment Indicator: Neutral. Tax-related sales are common and do not provide insight into insider sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote explicitly states, "Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards." This confirms the non-discretionary nature of the disposition.
Topics:#SECFiling#InsiderTrading#ARTV#ArtivaBiotherapeutics#Form4#CFO#StockMarket#TaxWithholding

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.